๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Dabigatran etexilate mesilate - Medicines in Ireland

26 authorised products containing Dabigatran etexilate mesilate, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 26 authorised medicines
MedicineActive substanceLicence holderStatus
Dabigatran Etexilate 110 mg hard capsules
PA0126/386/002
Dabigatran etexilate mesilate Clonmel Healthcare Ltd Marketed
Dabigatran Etexilate 150 mg hard capsules
PA0126/386/003
Dabigatran etexilate mesilate Clonmel Healthcare Ltd Marketed
Dabigatran Etexilate 75 mg hard capsules
PA0126/386/001
Dabigatran etexilate mesilate Clonmel Healthcare Ltd Not marketed
Dabigatran etexilate Accord 110 mg hard capsules
EU/1/22/1665/007-016
Dabigatran etexilate mesilate Accord Healthcare S.L.U. โ€”
Dabigatran etexilate Accord 150 mg hard capsules
EU/1/22/1665/017-024
Dabigatran etexilate mesilate Accord Healthcare S.L.U. โ€”
Dabigatran etexilate Accord 75 mg hard capsules
EU/1/22/1665/001-006
Dabigatran etexilate mesilate Accord Healthcare S.L.U. โ€”
Dabigatran etexilate Clonmel 110 mg hard capsules
PA0126/340/002
Dabigatran etexilate mesilate Clonmel Healthcare Ltd Not marketed
Dabigatran etexilate Clonmel 150 mg hard capsules
PA0126/340/003
Dabigatran etexilate mesilate Clonmel Healthcare Ltd Not marketed
Dabigatran etexilate Clonmel 75 mg hard capsules
PA0126/340/001
Dabigatran etexilate mesilate Clonmel Healthcare Ltd Not marketed
Dabigatran etexilate Gedeon Richter 110 mg hard capsules
PA1330/033/001
Dabigatran etexilate mesilate Gedeon Richter Plc Not marketed
Dabigatran etexilate Gedeon Richter 150 mg hard capsules
PA1330/033/002
Dabigatran etexilate mesilate Gedeon Richter Plc Not marketed
Dabigatran Etexilate Krka 110 mg hard capsules
PA1347/110/002
Dabigatran etexilate mesilate KRKA, d.d., Novo mesto Marketed
Dabigatran Etexilate Krka 150 mg hard capsules
PA1347/110/003
Dabigatran etexilate mesilate KRKA, d.d., Novo mesto Marketed
Dabigatran Etexilate Krka 75 mg hard capsules
PA1347/110/001
Dabigatran etexilate mesilate KRKA, d.d., Novo mesto Not marketed
Dabigatran etexilate Rowa 110 mg hard capsules
PA0074/095/001
Dabigatran etexilate mesilate Rowa Pharmaceuticals Limited, Not marketed
Dabigatran etexilate Rowa 150 mg hard capsules
PA0074/095/002
Dabigatran etexilate mesilate Rowa Pharmaceuticals Limited, Not marketed
Dabigatran etexilate Teva 110 mg hard capsules
EU/1/23/1769/007-015
Dabigatran etexilate mesilate TEVA GmbH โ€”
Dabigatran etexilate Teva 150 mg hard capsules
EU/1/23/1769/016-023
Dabigatran etexilate mesilate TEVA GmbH โ€”
Dabigatran etexilate Teva 75 mg hard capsules
EU/1/23/1769/001-006
Dabigatran etexilate mesilate TEVA GmbH โ€”
Pradaxa 110 mg coated granules
EU/1/08/442/0029
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH โ€”
Pradaxa 150 mg coated granules
EU/1/08/442/030
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH โ€”
Pradaxa 150 mg hard capsules
EU/1/08/442/009-013
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH โ€”
Pradaxa 20 mg coated granules
EU/1/08/442/025
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH โ€”
Pradaxa 30 mg coated granules
EU/1/08/442/0026
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH โ€”
Pradaxa 40 mg coated granules
EU/1/08/442/0027
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH โ€”
Pradaxa 50 mg coated granules
EU/1/08/442/028
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.